Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence ISASAEELR
Primary information
sequence IDSeq_3901
Peptide sequenceISASAEELR
CancerPDF_ID CancerPDF_ID369, CancerPDF_ID1356, CancerPDF_ID2552,
PMID19795908,21136997,21136997
Protein NameApolipoprotein A-IV,Apolipoprotein A-IV,Apolipoprotein A-IV
UniprotKB Entry NameAPOA4_HUMAN,APOA4_HUMAN,APOA4_HUMAN
FluidPlasma,Serum,Plasma
M/Z488.26,974.50327,974.5033
Charge2,1,1
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueMALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS
Quantification TechniqueLC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS
Labelled/Label FreeLabelled,Label Free,Label Free
FDRless than 7%,NA,0.001
CancerPDF_ID CancerPDF_ID369, CancerPDF_ID1356, CancerPDF_ID2552,
p-ValueNA,5.98E-05,5.98E-05
SoftwareFlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01)
Length9,9,9
Cancer TypeDuctal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Normal
DatabaseNCBI refseq Protein Database,SwissProt Database,SwissProt Database
ModificationNA,NA,NA
Number of Patients"40 normal, 28 patients",30 patients and 30 healthy controls,27 healthy individuals
RegulationNA,NA,Differentially expressed between cancer vs normal
ValidationNA,Leave One out Cross validation,Leave One out Cross validation
SensitivityNA,0.898,0.898
SpecificityNA,0.946,0.946
AccuracyNA,NA,0.917
Peptide AtlasPeptideAtlas
IEDB